ASCO updates stage IV driver-negative NSCLC guidance: put molecular testing first, add Teliso‑V, and navigate murky frontline choices.
Joshua Reuss, MD
Joshua Reuss, MD, is a thoracic medical oncologist at Georgetown University.
Articles by Joshua Reuss, MD
An interview with Joshua Reuss, MD, thoracic medical oncologist at Georgetown University and co-author of the guidelines.
